Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Patches for Capecitabine-Induced Hand-Foot Syndrome
NCT00751101Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Aug 2007
- Primary completion
- Mar 2014
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine patch in palmar-plantar erythrodysesthesia (PPE), sponsored by University of California, San Francisco. Started Aug 2007; status: terminated.
02
Drugs
nicotine patch
03
Conditions
palmar-plantar erythrodysesthesia (PPE)
Beyond the preview
Go deeper on NCT00751101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751101.